Related Experiment Video

Updated: Nov 27, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.8K

Therapeutic potential of p53 reactivation in cervical cancer

Xiangxuan Zhao1, Wei Sun1, Ying Ren1

  • 1Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, 110004, LN, China.

Critical Reviews in Oncology/Hematology
|December 4, 2020
PubMed

Insights

Restoring the tumor suppressor p53 function shows promise for treating cervical cancer (CC). Reactivating p53 can overcome treatment resistance and inhibit tumor growth, offering new therapeutic avenues for this common women's cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Cervical cancer (CC) is a leading cause of cancer-related deaths in women globally.
  • Early-stage CC is treatable with surgery, but metastatic or recurrent cases have a poor prognosis.
  • Dysfunctional tumor suppressor p53 is linked to therapeutic resistance and relapse in CC.

Purpose of the Study:

  • To review the potential of p53 reactivation as a therapeutic strategy for cervical cancer.
  • To explore the molecular mechanisms underlying p53's role in CC treatment.
  • To guide the development of novel therapies targeting p53 in CC.

Main Methods:

  • Literature review of studies on p53 function and cervical cancer.
  • Analysis of molecular mechanisms involving p53 in CC.
  • Synthesis of current research on p53 reactivation strategies.

Main Results:

  • Restoration of p53 activity can induce apoptosis and cell cycle arrest in CC cells.
  • Activated p53 can overcome radio- and chemotherapy resistance in CC.
  • p53 reactivation demonstrates potential for inhibiting tumor growth in CC.

Conclusions:

  • Activating wild-type p53 or restoring its function is a promising therapeutic strategy for cervical cancer.
  • Targeting p53 offers a novel approach to combatting therapeutic insensitivity and relapse in CC.
  • Further research into p53 reactivation mechanisms can lead to improved CC treatments.
Keywords:
Cervical cancerPrognosisSignaling pathwayTargeted therapyp53

More Related Videos

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.2K
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.6K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K